Eli Lilly and Company (NYSE:LLY) is among the 14 Best Pharma Dividend Stocks to Buy in 2025, showing consistent dividend growth with a 16% annual increase. The company holds a leading position in the weight loss segment and has a promising pipeline with potential blockbuster drugs. Its recent quarterly dividend was $1.50 per share, with an 11-year track record of dividend growth and a current yield of 0.77%.

Read more at Yahoo Finance: Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025